These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 5994564)
21. [Use of a sensory conditioning test in patients treated with psychotropic drugs]. Agathon M; Roussel A Int Pharmacopsychiatry; 1973; 8(4):221-33. PubMed ID: 4773019 [No Abstract] [Full Text] [Related]
22. Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain. Rastogi RB; Lapierre YD; Singhal RL; Nair NP Adv Biochem Psychopharmacol; 1980; 24():283-9. PubMed ID: 6996443 [No Abstract] [Full Text] [Related]
23. [Effect of neurotropic drugs on the escape reaction of 1 animal to pain stimulation of another]. Burov IuV; Speranskaia NP Zh Vyssh Nerv Deiat Im I P Pavlova; 1971; 21(3):618-20. PubMed ID: 5564143 [No Abstract] [Full Text] [Related]
24. [Secondary conditioned response as a method for studying benzodiazepine derivatives]. Zoni G; Banfi S Farmaco Sci; 1970 Mar; 25(3):177-86. PubMed ID: 5453294 [No Abstract] [Full Text] [Related]
25. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. Higgins GA; Joharchi N; Sellers EM J Pharmacol Exp Ther; 1993 Mar; 264(3):1440-9. PubMed ID: 8450478 [TBL] [Abstract][Full Text] [Related]
26. Serotonin: a behaviorally active compound in the caudate nucleus of cats. Cools AR Isr J Med Sci; 1973; 9 Suppl():5-16. PubMed ID: 10189867 [No Abstract] [Full Text] [Related]
27. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia. Bishnoi M; Chopra K; Kulkarni SK Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104 [TBL] [Abstract][Full Text] [Related]
29. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. Stanhope KJ; Mirza NR; Bickerdike MJ; Bright JL; Harrington NR; Hesselink MB; Kennett GA; Lightowler S; Sheardown MJ; Syed R; Upton RL; Wadsworth G; Weiss SM; Wyatt A J Pharmacol Exp Ther; 2001 Nov; 299(2):782-92. PubMed ID: 11602695 [TBL] [Abstract][Full Text] [Related]
30. (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Horan B; Smith M; Gardner EL; Lepore M; Ashby CR Synapse; 1997 May; 26(1):93-4. PubMed ID: 9097409 [TBL] [Abstract][Full Text] [Related]
31. Morphine sex-dependently induced place conditioning in adult Wistar rats. Karami M; Zarrindast MR Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832 [TBL] [Abstract][Full Text] [Related]
32. The effects of naloxone, chlorpromazine, and haloperidol pretreatment on levallorphan-induced disruption of rats' operant behaviour. Wray SR; Cowan A Psychopharmacologia; 1971; 22(3):261-70. PubMed ID: 5132008 [No Abstract] [Full Text] [Related]
33. Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning. Rudy JW Neurobiol Learn Mem; 1996 Jan; 65(1):73-81. PubMed ID: 8673409 [TBL] [Abstract][Full Text] [Related]
34. [Operant behavior and emotional conditioning in the evaluation of central pharmacological actions]. Cannizzaro G; Cascio G; Traina F Acta Neurol (Napoli); 1966; 21(1):69-77. PubMed ID: 5999247 [No Abstract] [Full Text] [Related]
35. Dopamine agonists and antagonists can produce an attenuation of response bias in a temporal discrimination task depending on discriminability of target duration. Harper DN; Bizo LA; Peters H Behav Processes; 2006 Feb; 71(2-3):286-96. PubMed ID: 16413975 [TBL] [Abstract][Full Text] [Related]
36. [Effects of N-methyl-3-hydroxypiperine benzilate(JB 336) on some conditioning responses of the rat]. Rump S; Faff J; Siek S Acta Physiol Pol; 1967; 18(1):89-95. PubMed ID: 6031987 [No Abstract] [Full Text] [Related]
37. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys. Spealman RD; Kelleher RT; Goldberg SR; DeWeese J; Goldberg DM J Pharmacol Exp Ther; 1983 Jan; 224(1):127-34. PubMed ID: 6848739 [TBL] [Abstract][Full Text] [Related]
38. Effects of drug discrimination history on the generalization of pentobarbital to other drugs. McMillan DE; Sun WL; Hardwick WC J Pharmacol Exp Ther; 1996 Jul; 278(1):50-61. PubMed ID: 8764335 [TBL] [Abstract][Full Text] [Related]
39. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol. Millan MJ; Brocco M; Gobert A; Schreiber R; Dekeyne A J Pharmacol Exp Ther; 1999 Mar; 288(3):1002-14. PubMed ID: 10027837 [TBL] [Abstract][Full Text] [Related]
40. [Thyroid psychobiology and conditioning]. Cavalca GG; Boncinelli A; Costa N Riv Sper Freniatr Med Leg Alien Ment; 1971 Apr; 95(2):341-51. PubMed ID: 5091475 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]